The mouse age phenome knowledgebase and disease-specific inter-species age mapping

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Geifman, Nophar ^a   Rubin, Eitan ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ANEMIA; ARTICLE; CLUSTER ANALYSIS; DATA MINING; KNOWLEDGE BASE; LEUKEMIA; MEASUREMENT ACCURACY; MOUSE MODEL; PHENOTYPE; SPECIES COMPARISON;

AGING; ANIMALS; DATA MINING; DATABASES, FACTUAL; DISEASE MODELS, ANIMAL; HUMANS; KNOWLEDGE BASES; MICE; SPECIES SPECIFICITY;

EID: 84891805774     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081114     Document Type: Article

References (29)

1. Peters LL, Robledo RF, Bult CJ, Churchill GA, Paigen BJ, et al. (2007) The mouse as a model for human biology: a resource guide for complex trait analysis. Nat Rev Genet 8: 58-69.
2. Bedell MA, Jenkins NA and Copeland NG (1997) Mouse models of human disease. Part I: techniques and resources for genetic analysis in mice. Genes Dev 11: 1-10.
3. Mestas J and Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172: 2731-2738.
4. Pedotti R, De Voss JJ, Steinman L and Galli SJ (2003) Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol 24: 479-484.
5. Morgan D (2011) Immunotherapy for Alzheimer's disease. J Intern Med 269: 54-63.
6. Diamond SG, Markham CH, Hoehn MM, McDowell FH and Muenter MD (1989) Effect of age at onset on progression and mortality in Parkinson's disease. Neurology 39.
7. Hasenclever D and Diehl V (1998) A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 339: 1506-1514.
8. Vecht CJ (1993) Effect of age on treatment decisions in low-grade glioma. J Neurol Neurosurg Psychiatry 56: 1259-1264.
9. Dewachter I, Moechars D, van Dorpe J, Tesseur I, Van den Haute C, et al. (2001) Modelling Alzheimer's disease in multiple transgenic mice. Biochem Soc Symp: 203-210.
10. Otis EM and Brent R (1954) Equivalent ages in mouse and human embryos. The Anatomical record 120: 33-63.
11. Geifman N and Rubin E (2011) Towards an Age-Phenome Knowledge-base. BMC Bioinformatics 12: 229.
12. Geifman N and Rubin E (2012) The age-phenome database. SpringerPlus 1: 1-8.
13. Geifman N, Cohen R and Rubin E (2013) Redefining meaningful age groups in the context of disease. AGE 1-10.
14. MySQL http://www.mysql.com/.
15. PubMed (2011) http://www.ncbi.nlm.nih.gov/pubmed/.
16. Disease Ontology http://do-wiki.nubic.northwestern.edu.
17. Bodenreider O (2004) The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res 32: D267-270.
18. Sharan R, Maron-Katz A and Shamir R (2003) CLICK and EXPANDER: a system for clustering and visualizing gene expression data. Bioinformatics 19: 1787-1799.
19. American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes care 29: 543-548.
20. Bjorntorp P (1988) Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 4: 615-622.
21. Hodge WG, Whitcher JP and Satariano W (1995) Risk factors for age-related cataracts. Epidemiol Rev 17: 336-346.
22. Hendrie HC (1997) Epidemiology of Alzheimer's disease. Geriatrics 52 Suppl 2: S4-8.
23. Vasto S, Carruba G, Lio D, Colonna-Romano G, Di Bona D, et al. (2009) Inflammation, ageing and cancer. Mech Ageing Dev 130: 40-45.
24. Shah KB, Inoue Y and Mehra MR (2006) Amyloidosis and the heart: a comprehensive review. Arch Intern Med 166: 1805-1813.
25. Coenen KR and Hasty AH (2007) Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice. Am J Physiol Endocrinol Metab 293: E492-499.
26. Jin XL, Sun WX, Shi YP, Li JH, Chen HM, et al. (2005) [Study on differentially expressed gene of the liver of treble fatty metabolism genes mutant mice using cDNA microarray]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22: 27-30.
27. Levy Z, Rachmani R, Trestman S, Dvir A, Shaish A, et al. (2003) Low-dose interferon-alpha accelerates atherosclerosis in an LDL receptor-deficient mouse model. Eur J Intern Med 14: 479-483.
28. Chen G, Paka L, Kako Y, Singhal P, Duan W, et al. (2001) A protective role for kidney apolipoprotein E. Regulation of mesangial cell proliferation and matrix expansion. J Biol Chem 276: 49142-49147.
29. Luo W, Bodary PF, Shen Y, Wickenheiser KJ, Ohman MK, et al. (2011) Leptin receptor-induced STAT3-independent signaling pathways are protective against atherosclerosis in a murine model of obesity and hyperlipidemia. Atherosclerosis 214: 81-85.